Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder
Key facts
- Who runs it
- NYU Langone Health
- Where
- New York, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 308 people enrolled
- Started
- 5 May 2018
- Ended
- 24 Jan 2024
- Type of study
- Observational, 3 groups
- Treatments tested
- Tasked based functional MRI (fMRI)
- Eye Tracking Device
- Record updated
- 26 July 2024
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Fluent (speaking and writing) in English; Additional criteria for healthy controls (HC):
- Lifetime absence of major Axis I diagnosis according to Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria
- Not taking psychotropic medications
- No first-degree biological relatives with OCD; Additional criteria for siblings (SIB):
- First-degree biological sibling of a person with OCD; Additional criteria for OCD patients:
- Diagnosis of OCD according to DSM-5 criteria
Who cannot take part
- MRI contraindications such as claustrophobia, ferrous implants, braces, or pacemakers
- Present or previous diagnosis of psychosis, bipolar disorder, or major developmental disorder (autism spectrum disorder, intellectual developmental disorder) based on DSM-5 criteria
- Major neurological illness (e.g., self-reported history of organic mental syndromes, head trauma, migraines, seizures, other Central Nervous System (CNS) disease, or other significant medical illness that would make participation unsafe or unfeasible)
- Any disability or health problem that prevents them from completing study procedures (e.g. back problems, severe carpal tunnel syndrome, impaired vision that is not corrected with glasses or contact lenses, etc.)
- Present diagnosis of alcohol use disorder or substance use disorder (moderate or severe)
- Current moderate or high suicidality as assessed through the Mini International Neuropsychiatric Interview (MINI) 7.0.2 suicidality module
- Positive urine toxicology or pregnancy test
Where in United States
- New York University School of MedicineNew York, United States
About the trial
What the trial wants to find out
The Research Domain Criteria (RDoC) approach seeks to address the neurobiological mechanisms of sensory symptoms in patients with obsessive-compulsive disorder (OCD) by investigating dimensional components of behavior that more closely align with brain circuitry. This project focuses on the dimensional symptom of sensory phenomena (SP), which are uncomfortable or aversive sensory experiences that drive repetitive behaviors in OCD, including "not just right" sensations, physical urges, and sensations of disgust. SP are very prevalent, occurring in 60-80% of OCD patients, and experienced as highly distressing. Unfortunately, SP are not well addressed by standard treatment approaches, which may be in part because their neurobiological mechanisms are not well understood.
Read full original descriptionShow less
This project builds on our preliminary data to (1) investigate the neural mechanisms of SP in large OCD cohort showing the full range of SP severity and (2) probe for familial risk markers in unaffected siblings of patients. For Aim 1, SP will be measured in 100 OCD patients using the Sensory Phenomena Scale. Diffusion and fMRI data will be acquired during rest and fMRI tasks. In order to identify familial risk markers, Aim 2 will compare sensory phenomena and neural circuitry between OCD probands, 50 unaffected biological siblings of OCD patients, and 50 unrelated healthy controls without a family history of Axis 1 disorders.
The 3 groups in the trial
- OCD Proband
Healthy controls (HC, n=50) without a family history of OCD will be matched to SIB.
Treatment: Tasked based functional MRI (fMRI) and Eye Tracking Device
- OCD Siblings
Healthy controls (HC, n=50) without a family history of OCD will be matched to SIB.
Treatment: Tasked based functional MRI (fMRI) and Eye Tracking Device
- Healthy Controls
Healthy controls (HC, n=50) without a family history of OCD will be matched to SIB.
Treatment: Tasked based functional MRI (fMRI) and Eye Tracking Device
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 26 July 2024